|
Volumn 15, Issue 3, 2001, Pages 173-176
|
Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?
|
Author keywords
Cerebral haemorrhage; Glucocorticoid remedial alodosteronism; Hypokalaemia; Screening
|
Indexed keywords
ALDOSTERONE SYNTHASE;
AMILORIDE;
AMLODIPINE;
ANTIHYPERTENSIVE AGENT;
ATENOLOL;
BENDROFLUMETHIAZIDE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DEXAMETHASONE;
ENALAPRIL;
GLUCOCORTICOID;
SPIRONOLACTONE;
STEROID 11BETA MONOOXYGENASE;
THIAZIDE DIURETIC AGENT;
ADOLESCENT;
ADULT;
ARTICLE;
BRAIN HEMORRHAGE;
CHIMERA;
CLINICAL TRIAL;
DIAGNOSTIC VALUE;
DISEASE SEVERITY;
ESSENTIAL HYPERTENSION;
FAMILY HISTORY;
FEMALE;
GENE MUTATION;
HIGH RISK POPULATION;
HUMAN;
HYPERALDOSTERONISM;
HYPERTENSION;
HYPOKALEMIA;
INHERITANCE;
MAJOR CLINICAL STUDY;
MALE;
MASS SCREENING;
MORBIDITY;
MORTALITY;
PROSPECTIVE STUDY;
|
EID: 0035127446
PISSN: 09509240
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.jhh.1001152 Document Type: Article |
Times cited : (28)
|
References (15)
|